PharmEvolution 2017: III International Forum for Development of Pharmaceutical Industry in Russia

Analytical companies predict that the pharmaceutical market will show a positive trend in 2017. A favorable business-climate and investment attractiveness of the industry are due to the stabilization of the political situation in the USA.

The pharmaceutical business in Russia is also demonstrating a promising growth. In 2016 the sales has increased by 20%.  After important industry-specific solutions, the structure of the commercial market of medications has also changed. In September 2016, the industry underwent significant changes as compared to the same period of 2015: the share of medicines with an average cost of packaging has increased, at the same time the share of expensive medications has reduced while the average cost of packaging has gone up. Following the results of September 2016, the study showed that slightly more than a half of medicines in packs sold in the marker are domestic.

In the framework of the forum organized by business daily Vedomosti together with Kaluga Region Government, Agency for innovation development – center for cluster development of Kaluga region with the support of Kaluga Pharmaceutical Cluster, the discussion of industry perspective development will take place.

Key issues:

  • Analytical studies and forecasts of industry development.
  • Localization of a production and development of pharmaceutical clusters in Russia.
  • New Russian pharma: the future of domestic developments.
  • Modern technologies in pharma and digitalization of healthcare.
  • Price distribution in the market.

Audience 200+  

The event will bring together key players of the market: representatives and heads of federal governmental institutions and regional authorities, the biggest pharmaceutical companies, research and innovative business incubators, distribution centers and pharmacy chains, industry associations, unions, funds, management companies and major analysts, investors, experts and mass media.

The project of the programme

10:00 – 11:00. Registration, welcome coffee

11:00 – 13:00. Discussion session 1. A pharmaceutical cluster as an investment driver of the industry development

Key issues:

  • Development of pharmaceutical clusters in Russia: functioning features, forecasts, new growth factors.  
  • Next step. What is next after the localization?  Long-term strategy of the development.
  • Formation of a pattern of behavior for each cluster in Russia. Territorial belonging of clusters according to their specialization and other measures to increase the efficiency.
  • Development and support of medications in Russia.

Invited participants:

Anatoly Artamonov, Governor of Kaluga Region*

Zakhar Golant, Chairman of the Board, Union of Pharmaceutical and Biomedical Clusters

Ivan Glushkov, President of the Board, Kaluga Pharmaceutical Cluster*

Igor Kagramanyan, Deputy Minister of Healthcare of the Russian Federation

Juergen Koenig, President and General Director, Merck Russia & CIS

Oleg Korzinov, Executive Director, Development Center Biopharmcluster “Severniy”

Anna Mityanina, Vice-Governor of St.Petersburg

Sergey Nazarov, Deputy Minister of Economic Development of the Russian Federation

Iskra Reich, Vice-President Russia & Eurasia, AstraZeneca

Peter Rodionov, CEO, Geropharm

Sergey Tsib, Deputy Minister of Industry and Trade of the Russian Federation*

13:00 – 14:00. Lunch

14:00 – 15:30. Discussion session 2. New Russian pharma: wonder or a perspective reality

Key issues:

  • Evolution of Russian pharmaceutical industry. Strategies of production of modern medications.
  • What can Russian pharma do? Developments of innovative medicines.
  • Demand for medications. What do major customers need?
  • How to make the promotion and entering the market more successful?
  • Inviolability of patents and development of competition.

Invited participants:

Victor Dmitriyev, CEO, ARFP (Association of Russian pharmaceutical manufacturers)

Andrey Ivaschenko, Chairman of the Board of Directors, Chemrar

Olga Kolotilova, Director of the Department for Development of Pharmaceutical and Medical Industry, Ministry of Industry and Trade of the Russian Federation

Dmitry Kudlay, CEO, Generium

Elena Maksimkina, Director of the Department for Medicinal Drug Supply and Regulation of Medical Devises Circulation, Ministry of Healthcare of the Russian Federation

Alexander Malin, CEO, Nativa

14:00 – 15:30. Discussion session 2.2. Pricing and new procurement models

Key issues:

  • Price distribution in the market. Mechanisms and new systems of effective collaboration between the state and business. Models and methods of pricing.
  • Calculation of reference prices in respect of the procurement of medicines. Legislative initiatives and changes in the market.
  • Decrease in the price level. Forecasts of the industry.
  • Influence on the market of centralized purchases, simplified pricing for domestic producers and inexpensive medicines.

Invited participants:

Konstantin Baranov, Minister of Healthcare of Kaluga Region

Elena Maksimkina, Director of the Department for Medicinal Drug Supply and Regulation of Medical Devises Circulation, Ministry of Healthcare of the Russian Federation

Timofey Nizhegorodtsev, Head of the Department for Control over Social Sphere and Trade, Federal Antimonopoly Service of the Russian Federation

Vitaly Omelyanovskiy, CEO, Center for Healthcare Quality Assessment and Control of the Ministry of Healthcare of the Russian Federation

Daria Starykh, Head of the Division for Regulating Pharmaceutical Prices, Federal Antimonopoly Service of the Russian Federation

Sergey Shulyak, CEO, DSM Group

Alexander Kholopov, Head of the Department for Healthcare, Tomsk Region

15:30 – 16:00. Coffee break

16:00 – 17:30. Discussion session 3. Digital in pharmacy and medicine

Key issues: 

  • Modern principles of operation. How has the digitalization fundamentally changed the industry?
  • How to establish effective work of electronic prescription in case of distance selling?
  • Increase of business transparency: system of monitoring of purchasing and marking of medications. Perspectives of pilot projects.
  • Telemedicine and the development of its main directions in Russia. Electronic card and electronic sick leave.

Invited participants:

Grigory Bakunov, Director of Spreading Technology, Yandex

Kirill Varlamov, Director, Internet Initiatives Development Fund

Ruslan Zaydullin, Cofounder and CEO, DOC+*

Maria Izmestieva, Director of Innovative Projects, Teva

German Klimenko, Presidential Internet Adviser, Presidential Administration of Russia

Mikhail Konovalov, Head of IT CIS, Bayer

Leonid Levin, Chairman of the Committee on Information Policy, Information Technology, and Communications, State Duma of the Russian Federation

Mikhail Murashko, Head of the Federal Service for Supervision of Healthcare of the Russian Federation

Konstantin Solodukhin, CEO, National Center of Informatization (NIC)

17:30 – The end of the forum. Evening cocktail. 

*confirmed speakers

April 04, 2017

Investment digest

Printed products